Gu, Wei
Deng, Xianding
Lee, Marco
Sucu, Yasemin D.
Arevalo, Shaun
Stryke, Doug
Federman, Scot
Gopez, Allan
Reyes, Kevin
Zorn, Kelsey http://orcid.org/0000-0003-1227-2137
Sample, Hannah
Yu, Guixia
Ishpuniani, Gurpreet
Briggs, Benjamin
Chow, Eric D. http://orcid.org/0000-0001-8079-918X
Berger, Amy
Wilson, Michael R. http://orcid.org/0000-0002-8705-5084
Wang, Candace
Hsu, Elaine
Miller, Steve
DeRisi, Joseph L.
Chiu, Charles Y. http://orcid.org/0000-0003-2915-2094
Funding for this research was provided by:
Abbott Laboratories
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01-HL105704)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R33-AI120977)
U.S. Department of Health & Human Services | National Institutes of Health (K08-CA230156-01)
Burroughs Wellcome Fund
Article History
Received: 16 January 2020
Accepted: 17 September 2020
First Online: 9 November 2020
Competing interests
: C.Y.C. is the director of the UCSF-Abbott Viral Diagnostics and Discovery Center and receives research support funding from Abbott Laboratories, Inc. C.Y.C., D.S., S.F. and S.M. are inventors on a patent application on algorithms related to SURPI+ software (no. PCT/US/16/52912, ‘Pathogen Detection using Next-Generation Sequencing’). C.Y.C., X.D. and S.F. are inventors on a patent pending on algorithms related to SURPI<i>rt</i> software (Case no. SF2015-154, ’Methods for Real-Time Sequencing Analysis of Infectious Diseases’). Other coauthors declare no competing interests.